Crigler-Najjar Syndrome Drug Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Crigler-Najjar Syndrome Drug
1.2 Key Market Segments
1.2.1 Crigler-Najjar Syndrome Drug Segment by Type
1.2.2 Crigler-Najjar Syndrome Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Crigler-Najjar Syndrome Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Crigler-Najjar Syndrome Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Crigler-Najjar Syndrome Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Crigler-Najjar Syndrome Drug Market Competitive Landscape
3.1 Global Crigler-Najjar Syndrome Drug Sales by Manufacturers (2019-2024)
3.2 Global Crigler-Najjar Syndrome Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Crigler-Najjar Syndrome Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Crigler-Najjar Syndrome Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Crigler-Najjar Syndrome Drug Sales Sites, Area Served, Product Type
3.6 Crigler-Najjar Syndrome Drug Market Competitive Situation and Trends
3.6.1 Crigler-Najjar Syndrome Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Crigler-Najjar Syndrome Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Crigler-Najjar Syndrome Drug Industry Chain Analysis
4.1 Crigler-Najjar Syndrome Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Crigler-Najjar Syndrome Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Crigler-Najjar Syndrome Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Crigler-Najjar Syndrome Drug Sales Market Share by Type (2019-2024)
6.3 Global Crigler-Najjar Syndrome Drug Market Size Market Share by Type (2019-2024)
6.4 Global Crigler-Najjar Syndrome Drug Price by Type (2019-2024)
7 Crigler-Najjar Syndrome Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Crigler-Najjar Syndrome Drug Market Sales by Application (2019-2024)
7.3 Global Crigler-Najjar Syndrome Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Crigler-Najjar Syndrome Drug Sales Growth Rate by Application (2019-2024)
8 Crigler-Najjar Syndrome Drug Market Segmentation by Region
8.1 Global Crigler-Najjar Syndrome Drug Sales by Region
8.1.1 Global Crigler-Najjar Syndrome Drug Sales by Region
8.1.2 Global Crigler-Najjar Syndrome Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Crigler-Najjar Syndrome Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Crigler-Najjar Syndrome Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Crigler-Najjar Syndrome Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Crigler-Najjar Syndrome Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Crigler-Najjar Syndrome Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Audentes Therapeutics Inc
9.1.1 Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Basic Information
9.1.2 Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Product Overview
9.1.3 Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Product Market Performance
9.1.4 Audentes Therapeutics Inc Business Overview
9.1.5 Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug SWOT Analysis
9.1.6 Audentes Therapeutics Inc Recent Developments
9.2 Genethon SA
9.2.1 Genethon SA Crigler-Najjar Syndrome Drug Basic Information
9.2.2 Genethon SA Crigler-Najjar Syndrome Drug Product Overview
9.2.3 Genethon SA Crigler-Najjar Syndrome Drug Product Market Performance
9.2.4 Genethon SA Business Overview
9.2.5 Genethon SA Crigler-Najjar Syndrome Drug SWOT Analysis
9.2.6 Genethon SA Recent Developments
9.3 International Stem Cell Corp
9.3.1 International Stem Cell Corp Crigler-Najjar Syndrome Drug Basic Information
9.3.2 International Stem Cell Corp Crigler-Najjar Syndrome Drug Product Overview
9.3.3 International Stem Cell Corp Crigler-Najjar Syndrome Drug Product Market Performance
9.3.4 International Stem Cell Corp Crigler-Najjar Syndrome Drug SWOT Analysis
9.3.5 International Stem Cell Corp Business Overview
9.3.6 International Stem Cell Corp Recent Developments
9.4 Promethera Biosciences SA
9.4.1 Promethera Biosciences SA Crigler-Najjar Syndrome Drug Basic Information
9.4.2 Promethera Biosciences SA Crigler-Najjar Syndrome Drug Product Overview
9.4.3 Promethera Biosciences SA Crigler-Najjar Syndrome Drug Product Market Performance
9.4.4 Promethera Biosciences SA Business Overview
9.4.5 Promethera Biosciences SA Recent Developments
10 Crigler-Najjar Syndrome Drug Market Forecast by Region
10.1 Global Crigler-Najjar Syndrome Drug Market Size Forecast
10.2 Global Crigler-Najjar Syndrome Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Crigler-Najjar Syndrome Drug Market Size Forecast by Country
10.2.3 Asia Pacific Crigler-Najjar Syndrome Drug Market Size Forecast by Region
10.2.4 South America Crigler-Najjar Syndrome Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Crigler-Najjar Syndrome Drug by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Crigler-Najjar Syndrome Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Crigler-Najjar Syndrome Drug by Type (2025-2030)
11.1.2 Global Crigler-Najjar Syndrome Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Crigler-Najjar Syndrome Drug by Type (2025-2030)
11.2 Global Crigler-Najjar Syndrome Drug Market Forecast by Application (2025-2030)
11.2.1 Global Crigler-Najjar Syndrome Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Crigler-Najjar Syndrome Drug Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Crigler-Najjar Syndrome Drug Market Size Comparison by Region (M USD)
Table 5. Global Crigler-Najjar Syndrome Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Crigler-Najjar Syndrome Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Crigler-Najjar Syndrome Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Crigler-Najjar Syndrome Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crigler-Najjar Syndrome Drug as of 2022)
Table 10. Global Market Crigler-Najjar Syndrome Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Crigler-Najjar Syndrome Drug Sales Sites and Area Served
Table 12. Manufacturers Crigler-Najjar Syndrome Drug Product Type
Table 13. Global Crigler-Najjar Syndrome Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Crigler-Najjar Syndrome Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Crigler-Najjar Syndrome Drug Market Challenges
Table 22. Global Crigler-Najjar Syndrome Drug Sales by Type (Kilotons)
Table 23. Global Crigler-Najjar Syndrome Drug Market Size by Type (M USD)
Table 24. Global Crigler-Najjar Syndrome Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Crigler-Najjar Syndrome Drug Sales Market Share by Type (2019-2024)
Table 26. Global Crigler-Najjar Syndrome Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Crigler-Najjar Syndrome Drug Market Size Share by Type (2019-2024)
Table 28. Global Crigler-Najjar Syndrome Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Crigler-Najjar Syndrome Drug Sales (Kilotons) by Application
Table 30. Global Crigler-Najjar Syndrome Drug Market Size by Application
Table 31. Global Crigler-Najjar Syndrome Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Crigler-Najjar Syndrome Drug Sales Market Share by Application (2019-2024)
Table 33. Global Crigler-Najjar Syndrome Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Crigler-Najjar Syndrome Drug Market Share by Application (2019-2024)
Table 35. Global Crigler-Najjar Syndrome Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Crigler-Najjar Syndrome Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Crigler-Najjar Syndrome Drug Sales Market Share by Region (2019-2024)
Table 38. North America Crigler-Najjar Syndrome Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Crigler-Najjar Syndrome Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Crigler-Najjar Syndrome Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Crigler-Najjar Syndrome Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Crigler-Najjar Syndrome Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Basic Information
Table 44. Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Product Overview
Table 45. Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Audentes Therapeutics Inc Business Overview
Table 47. Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug SWOT Analysis
Table 48. Audentes Therapeutics Inc Recent Developments
Table 49. Genethon SA Crigler-Najjar Syndrome Drug Basic Information
Table 50. Genethon SA Crigler-Najjar Syndrome Drug Product Overview
Table 51. Genethon SA Crigler-Najjar Syndrome Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Genethon SA Business Overview
Table 53. Genethon SA Crigler-Najjar Syndrome Drug SWOT Analysis
Table 54. Genethon SA Recent Developments
Table 55. International Stem Cell Corp Crigler-Najjar Syndrome Drug Basic Information
Table 56. International Stem Cell Corp Crigler-Najjar Syndrome Drug Product Overview
Table 57. International Stem Cell Corp Crigler-Najjar Syndrome Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. International Stem Cell Corp Crigler-Najjar Syndrome Drug SWOT Analysis
Table 59. International Stem Cell Corp Business Overview
Table 60. International Stem Cell Corp Recent Developments
Table 61. Promethera Biosciences SA Crigler-Najjar Syndrome Drug Basic Information
Table 62. Promethera Biosciences SA Crigler-Najjar Syndrome Drug Product Overview
Table 63. Promethera Biosciences SA Crigler-Najjar Syndrome Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Promethera Biosciences SA Business Overview
Table 65. Promethera Biosciences SA Recent Developments
Table 66. Global Crigler-Najjar Syndrome Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 67. Global Crigler-Najjar Syndrome Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 68. North America Crigler-Najjar Syndrome Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 69. North America Crigler-Najjar Syndrome Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 70. Europe Crigler-Najjar Syndrome Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 71. Europe Crigler-Najjar Syndrome Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 72. Asia Pacific Crigler-Najjar Syndrome Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 73. Asia Pacific Crigler-Najjar Syndrome Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 74. South America Crigler-Najjar Syndrome Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 75. South America Crigler-Najjar Syndrome Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 76. Middle East and Africa Crigler-Najjar Syndrome Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 77. Middle East and Africa Crigler-Najjar Syndrome Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 78. Global Crigler-Najjar Syndrome Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 79. Global Crigler-Najjar Syndrome Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 80. Global Crigler-Najjar Syndrome Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 81. Global Crigler-Najjar Syndrome Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 82. Global Crigler-Najjar Syndrome Drug Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Crigler-Najjar Syndrome Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Crigler-Najjar Syndrome Drug Market Size (M USD), 2019-2030
Figure 5. Global Crigler-Najjar Syndrome Drug Market Size (M USD) (2019-2030)
Figure 6. Global Crigler-Najjar Syndrome Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Crigler-Najjar Syndrome Drug Market Size by Country (M USD)
Figure 11. Crigler-Najjar Syndrome Drug Sales Share by Manufacturers in 2023
Figure 12. Global Crigler-Najjar Syndrome Drug Revenue Share by Manufacturers in 2023
Figure 13. Crigler-Najjar Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Crigler-Najjar Syndrome Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Crigler-Najjar Syndrome Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Crigler-Najjar Syndrome Drug Market Share by Type
Figure 18. Sales Market Share of Crigler-Najjar Syndrome Drug by Type (2019-2024)
Figure 19. Sales Market Share of Crigler-Najjar Syndrome Drug by Type in 2023
Figure 20. Market Size Share of Crigler-Najjar Syndrome Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Crigler-Najjar Syndrome Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Crigler-Najjar Syndrome Drug Market Share by Application
Figure 24. Global Crigler-Najjar Syndrome Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Crigler-Najjar Syndrome Drug Sales Market Share by Application in 2023
Figure 26. Global Crigler-Najjar Syndrome Drug Market Share by Application (2019-2024)
Figure 27. Global Crigler-Najjar Syndrome Drug Market Share by Application in 2023
Figure 28. Global Crigler-Najjar Syndrome Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Crigler-Najjar Syndrome Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Crigler-Najjar Syndrome Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Crigler-Najjar Syndrome Drug Sales Market Share by Country in 2023
Figure 32. U.S. Crigler-Najjar Syndrome Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Crigler-Najjar Syndrome Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Crigler-Najjar Syndrome Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Crigler-Najjar Syndrome Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Crigler-Najjar Syndrome Drug Sales Market Share by Country in 2023
Figure 37. Germany Crigler-Najjar Syndrome Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Crigler-Najjar Syndrome Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Crigler-Najjar Syndrome Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Crigler-Najjar Syndrome Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Crigler-Najjar Syndrome Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Crigler-Najjar Syndrome Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Crigler-Najjar Syndrome Drug Sales Market Share by Region in 2023
Figure 44. China Crigler-Najjar Syndrome Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Crigler-Najjar Syndrome Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Crigler-Najjar Syndrome Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Crigler-Najjar Syndrome Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Crigler-Najjar Syndrome Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Crigler-Najjar Syndrome Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Crigler-Najjar Syndrome Drug Sales Market Share by Country in 2023
Figure 51. Brazil Crigler-Najjar Syndrome Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Crigler-Najjar Syndrome Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Crigler-Najjar Syndrome Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Crigler-Najjar Syndrome Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Crigler-Najjar Syndrome Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Crigler-Najjar Syndrome Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Crigler-Najjar Syndrome Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Crigler-Najjar Syndrome Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Crigler-Najjar Syndrome Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Crigler-Najjar Syndrome Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Crigler-Najjar Syndrome Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Crigler-Najjar Syndrome Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Crigler-Najjar Syndrome Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Crigler-Najjar Syndrome Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Crigler-Najjar Syndrome Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Crigler-Najjar Syndrome Drug Market Share Forecast by Application (2025-2030)
Industry Market Size
